-
J&J expands Phase 2a COVID-19 vaccine trial to include adolescents
expresspharma
April 06, 2021
Johnson & Johnson has begun vaccinating adolescent participants in the ongoing Phase 2a clinical trial for its COVID-19 vaccine candidate, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.
-
US gives charge of facility that botched COVID vaccine to J&J, stops AstraZeneca from using the plant
expresspharma
April 06, 2021
AstraZeneca, whose vaccine has not been approved in the US, said it will work with President Joe Biden’s administration to find an alternative site to produce its vaccine.
-
Prioritising who receives COVID-19 vaccine first saves lives: Research
expresspharma
April 06, 2021
They found that deaths, years of life lost and infections were between 17 and 44 per cent lower when vaccinations targeted vulnerable populations.
-
Pfizer and BioNTech’s Covid-19 vaccine shows 100% efficacy in adolescents
pharmaceutical-technology
April 02, 2021
Pfizer and BioNTech have reported that a Phase III trial of their Covid-19 vaccine, BNT162b2, showed 100% efficacy and strong antibody responses in adolescents aged 12 to 15 years with or without prior evidence of SARS-CoV-2 infection.
-
Millions of J&J Covid-19 vaccine doses scrapped after US ingredient mix-up
pharmaceutical-technology
April 02, 2021
Up to 15 million doses of Johnson & Johnson’s (J&J) Covid-19 vaccine have been ruined due to a mix-up with ingredients at a US production plant.
-
Pfizer COVID-19 vaccine safe, efficacious for adolescents
expresspharma
April 02, 2021
Whether COVID-19 vaccines work and are safe to use on children is one of the big questions drugmakers are trying to answer.
-
EU asks India for 10 million AstraZeneca vaccines to meet shortfall
expresspharma
April 02, 2021
Any quick approval of the EU request is unlikely, however, with India scrambling to expand its own domestic vaccination drive, said a Indian government official.
-
Iconovo signs agreement with ISR for the development of inhaled covid-19 vaccine
prnasia
April 01, 2021
Iconovo AB (publ), a company developing complete inhalation products for a global market, today announced that it has signed an agreement with the immunotherapy company Immune System Regulation AB (ISR) ...
-
Positive results for Pfizer/BioNTech’s COVID-19 vaccine in 12-15 year olds
pharmatimes
April 01, 2021
Pfizer and BioNTech have revealed positive top-line data for their COVID-19 vaccine – BNT162b2 – in adolescents aged 12 to 15 years old.
-
Canada's National Advisory Committee on Immunization Issues Warning Against AstraZeneca COVID-19 Vaccine
americanpharmaceuticalreview
April 01, 2021
Canada's National Advisory Committee on Immunization has recommended the AstraZeneca Covid-19 vaccine should not be used in adults under age 55 while rare cases of serious blood clots following vaccination are being investigated, according to a ...